Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

Pharma M&A Is all about Options

by | May 11, 2016 8:42 am | Pharmaceuticals

The days of mega-mergers in the pharmaceutical sector aren’t necessarily over, but those deals will be fewer and farther between, going forward. Nearly 60 deals have been announced in 2016 through the middle of May, and just 17 have an entire company as the target. The largest, so far, is Shire’s (NASDAQ: SHPG) $32 billion takeover of Baxalta (NYSE: BXLT), announced in January. The rest are either collaborations on product candidates, rights or license deals for marketed products or clinical-stage candidates, even the rights to royalties. That’s Royalty Pharma’s $1.1 billion deal for the royalty interest in Xtandi, which is being sold by a co-owner, UCLA, where... Read More »

Reporter’s Notebook: PE Healthcare Investor Forum 2016

by | May 10, 2016 7:21 pm | Private Equity

The first-ever Private Equity Healthcare Investor Forum took place in New York City on April 27, 2016 at the Westin Times Square. We were invited to attend by the sponsor, Private Equity International. The conference was originally planned to span two days, but was cut down to a single, panel-crammed event a few weeks before. Attendance was spotty, and at times it seemed the bulk of the audience were all speakers. Don’t get us wrong, we’d go again, if invited. The most interesting panel, in our opinion, was moderated by Richard Zall, partner and chair of Proskauer’s Health Care Department. Titled “When healthcare meets private equity: analyzing investor trends and... Read More »

Four More Behavioral Health Deals in May

by | May 10, 2016 6:20 pm | Behavioral Health Care, Private Equity

Mergers and acquisitions in the behavioral health care sector have picked up significantly in April and May. Although only eight deals were announced in the first quarter of 2016, nine more have come along in just the past six weeks. Four have been announced in the first 10 days of May, beginning with Acadia Healthcare Company (NASDAQ: ACHC) and its acquisition of TrustPoint Hospital in Murfreesboro, Tennessee from privately-held Polaris Hospital Company. TrustPoint is a 129-bed facility, and since the deal closed on May 1, Acadia has filed a certificate of need for another 100 beds. Moving north to Buffalo, New York, two not-for-profits merged to become one of the largest community-based... Read More »

Quintiles/IMS Merger Keeps Lab Sector Humming

by | May 6, 2016 9:25 pm | Laboratories, MRI & Dialysis

Laboratories are big business, and they’re trading for very strong multiples these days. This year in particular, we’ve seen a lot of global M&A action around contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). The most recent announcement was the all-stock merger of equals between Quintiles (NYSE: Q) and IMS Health Holdings (NYSE: IMS). First, the details. IMS Health shareholders will receive a fixed exchange ratio of 0.384 shares of Quintiles common stock for each share of IMS Health common stock. Upon completion, IMS shareholders will own approximately 51.4% of the shares of the combined company on a fully diluted... Read More »

PE Firms Target Revenue Cycle Management

by | May 5, 2016 1:49 pm | eHealth

Follow the money. Everywhere in health care today, controlling the flow of revenue is critical to success, from physician practices to hospitals, skilled nursing facilities and more. As critical as it is, revenue cycle management took a back seat to electronic medical records in recent years, as CMS enforced the early stages of Meaningful Use to get physician practices on board with EMRs. Now that the switch to the ICD-10 coding system is firmly in place, investors’ attention has turned back to revenue cycle management (RCM). In just the first four months of 2016, nine RCM companies have been acquired, surpassing 2014’s total of eight RCM deals, and putting this year on track to beat... Read More »

MEDNAX Looks to Improve the Patient Experience

by | May 4, 2016 5:45 pm | eHealth, Physician Medical Groups

MEDNAX , Inc. (NYSE: MD), once focused exclusively on managing neonatology and anesthesia practices, is moving to manage the entire patient experience. In August 2014, it acquired MedData, Inc., a revenue cycle management company for an undisclosed price. The plan was to provide management services to facilities and physician groups beyond its then-existing footprint. A year later, in September 2015, MedData brought aboard Alegis Revenue Group, a national third-party receivables company. Alegis managed more than $3 billion in charges for more than 240 hospitals nationwide. The company’s patient-advocacy approach to eligibility and enrollment cut revenue cycle time from referral to... Read More »

Geriatric Behavioral Health Companies Merge

by | May 4, 2016 12:16 am | Behavioral Health Care, Private Equity

MedOptions, Inc. of Old Lyme, Connecticut announced its acquisition of San Diego-based Vericare on May 2, 2016. Vericare provides geropsychology and geropsychiatry behavioral health services in skilled nursing facilities. It employs more than 400 licensed behavioral healthcare professionals in more than 600 facilities across eight states. Similarly, MedOptions provides behavioral health services to residents of skilled nursing homes in Connecticut, Maryland, Massachusetts, New Jersey and Pennsylvania. The two companies each provide a similar integrated behavioral care model to deliver services to a primarily geriatric population. The combined business will be the sole national provider of... Read More »

April Deal Volume Was Decent

by | Apr 29, 2016 6:51 pm | Biotechnology, eHealth, Long-Term Care

We’re still in preliminary territory, so don’t bank on this yet. Health care M&A hit 120 deals for the month of April 2016, down 12% versus the previous month’s 136 deals, but 7% better than the same month a year ago. Long-term care deals led the transaction activity with 21 deals (18% of the total), with Biotechnology (17 deals, 14%) and eHealth (16 deals, 13%) close behind. Thanks to the $30.7 billion Abbott (NYSE: ABT) offer for St. Jude Medical (NYSE: SJM), spending for the month was far higher than in recent months. April’s deal value now stands at $42.2 billion, up 240% compared with March’s $12.4 billion and 732% compared with April 2015’s... Read More »